Becton, Dickinson and Company (BD) has received the US Food and Drug Administration’s (FDA) 510(k) clearance for the Phasix ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced 510(k) clearance ...

BD (NYSE: BDX) announced today that it received FDA 510(k) clearance for its Phasix ST umbilical hernia patch.

Liver injury is an independent risk factor for multiple organ dysfunction and high mortality in patients with sepsis. However, the pathological mechanisms and therapeutic strategies for ...

Sodium DL-beta-hydroxybutyrate** and acetone†† were sterilized by filtration. The former was frozen at —18°C. in aliquots of 25 gm. per 200 ml. of water, and the latter was kept at room ...